Ghent University Academic Bibliography

Your filters: cql: author exact F50FCA64-F0ED-11E1-A9DE-61C894A0A6B4

Add to list
- Journal Article
- A2
- open access
Case series of kaposi sarcoma in HIV-negative men who have sex with men : potential therapeutic approaches

Niels Hilhorst (UGent) , Barbara Devocht, Evelien Verhaeghe (UGent) , Lore Lapeire (UGent) , Linos Vandekerckhove (UGent) , Soetkin Desmet, Marie-Angélique De Scheerder (UGent) and Lieve Brochez (UGent)

(2024) JOURNAL OF DERMATOLOGY RESEARCH AND THERAPY. 10(1). p.1-6
Add to list
- Journal Article
- A1
Cost-of-illness of skin cancer : a systematic review

Annick Meertens (UGent) , Laura Van Coile (UGent) , Tijs Van Iseghem (UGent) , Lieve Brochez (UGent) , Nick Verhaeghe (UGent) and Isabelle Hoorens (UGent)

(2024) PHARMACOECONOMICS. 42(7). p.751-765
Add to list
- Journal Article
Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them.

Claus Garbe, Ana-Maria Forsea, Teresa Amaral, Petr Arenberger, Philippe Autier, Marianne Berwick, Brigitta Boonen, Matilda Bylaite, Veronique del Marmol, Brigitte Dreno, et al.

(2024) European Journal of Cancer. 204.
Add to list
- Journal Article
The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study

Sofie Mylle, Jorien Papeleu, Isabelle Hoorens (UGent) , Evelien Verhaeghe (UGent) and Lieve Brochez (UGent)

(2024) JMIR Dermatology. 7.
Add to list
- Miscellaneous
Angiosarcoma mimicking rhinophyma

Niels Hilhorst (UGent) , Evelien Verhaeghe (UGent) and Lieve Brochez (UGent)

(2023) JAMA DERMATOLOGY. 159(1). p.95-95
Add to list
- Journal Article
- A1
Dermatologist versus artificial intelligence confidence in dermoscopy diagnosis : complementary information that may affect decision-making

Pieter Van Molle (UGent) , Sofie Mylle (UGent) , Tim Verbelen (UGent) , Cedric De Boom, Bert Vankeirsbilck (UGent) , Evelien Verhaeghe (UGent) , Bart Dhoedt (UGent) and Lieve Brochez (UGent)

(2023) EXPERIMENTAL DERMATOLOGY. 32(10). p.1744-1751
Add to list
- Journal Article
- A1
- open access
Comparative analysis of cooling methods for dynamic infrared thermography (DIRT)-based skin cancer diagnosis

Jan Verstockt, Filip E. F. Thiessen, Isabelle Hoorens (UGent) , Lieve Brochez (UGent) and Gunther Steenackers

(2023) APPLIED SCIENCES-BASEL. 13(18).
Add to list
- Journal Article
- A1
- open access
Impact of the COVID-19 pandemic on the incidence and thickness of cutaneous melanoma in Belgium

Philip Georg Demaerel, Arthur Leloup, Lieve Brochez (UGent) , Liesbet Van Eycken and Marjan Garmyn

(2023) BIOMEDICINES. 11(6).
Add to list
- Journal Article
- A1
- open access
Can multispectral dermoscopy help in distinguishing blue color?

Laudine Janssen, Sofie Van Kelst, Bart Diricx, Tom Kimpe, Jorien Papeleu, Evelien Verhaeghe (UGent) , Lieve Brochez (UGent) and Marjan Garmyn

(2023) DERMATOLOGY PRACTICAL & CONCEPTUAL. 13(1).
Add to list
- Journal Article
- A1
- open access
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023

Ketty Peris, Maria Concetta Fargnoli, Roland Kaufmann, Petr Arenberger, Lars Bastholt, Nicole Basset Seguin, Veronique Bataille, Lieve Brochez (UGent) , Veronique del Marmol, Reinhard Dummer, et al.

(2023) EUROPEAN JOURNAL OF CANCER. 192.
Add to list
- Conference Paper
- C3
Cost-of-illness of skin cancer : a systematic literature review

Annick Meertens (UGent) , Laura Van Coile (UGent) , Tijs Van Iseghem (UGent) , Lieve Brochez (UGent) , Nick Verhaeghe (UGent) and Isabelle Hoorens (UGent)

(2023) VALUE IN HEALTH. In Value in Health 26(12, Supplement). p.S542-S542
Add to list
- Journal Article
- A1
Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Mathieu Spaas (UGent) , Nora Sundahl, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Fréderic Duprez (UGent) , Yolande Lievens (UGent) , Veerle Surmont (UGent) , Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2023) JAMA ONCOLOGY. 9(9). p.1205-1213
Add to list
- Journal Article
- A1
Truth or dare : switching BRAF/MEK inhibitors after acute interstitial nephritis in a patient with metastatic melanoma : a case report and review of the literature

Lore De Ryck, Sigurd Delanghe (UGent) , Celine Jacobs (UGent) , Sharareh Fadaei (UGent) , Lieve Brochez (UGent) and Michael Saerens (UGent)

(2023) ACTA CLINICA BELGICA. 78(3). p.215-222
Add to list
- Journal Article
- A1
The therapeutic dilemma of basal cell carcinoma in older adults : a review of the current literature

Laura Van Coile (UGent) , Evelien Verhaeghe (UGent) , Katia Ongenae (UGent) , Laura Destrooper, Zahra Mohamadi, Lieve Brochez (UGent) and Isabelle Hoorens (UGent)

(2023) JOURNAL OF GERIATRIC ONCOLOGY. 14(3).
Add to list
- Journal Article
- A1
A critical re‐evaluation of Mohs micrographic surgery for a facial basal cell carcinoma in older adults : should we waive this treatment in certain patients?

Laura Van Coile (UGent) , Lieve Brochez (UGent) , Evelien Verhaeghe (UGent) , Barbara Boone (UGent) , Annick Meertens (UGent) , Katia Ongenae (UGent) and Isabelle Hoorens (UGent)

(2023) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 37(9). p.1792-1798
Add to list
- Journal Article
- A1
- open access
Study protocol of the BASINEL Study : a pragmatic randomised controlled trial investigating treatment versus no treatment of low-risk basal cell carcinomas in older persons

Laura Van Coile (UGent) , Evelien Verhaeghe (UGent) , Katia Ongenae (UGent) , Lieve Brochez (UGent) and Isabelle Hoorens (UGent)

(2022) BMJ OPEN. 12(11).
Add to list
- Journal Article
- A1
Response to the comment by Suijkerbuijk et al. ‘Survival of stage IV melanoma in Belgium and the Netherlands’

B. Reyn, E. Van Eycken, M. Louwman, K. Henau, K. Schreuder, Lieve Brochez (UGent) , M. Garmyn and N.A. Kukutsch

(2022) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 36(2). p.E119-E119
Add to list
- Miscellaneous
- open access
Basal cell carcinoma in older adults : how to decide when active surveillance or watchful waiting are appropriate?

Laura Van Coile (UGent) , Evelien Verhaeghe (UGent) , Katia Ongenae (UGent) , Lieve Brochez (UGent) and Isabelle Hoorens (UGent)

(2022) BRITISH JOURNAL OF DERMATOLOGY. 187(2). p.244-245
Add to list
- Journal Article
- A1
- open access
Health state utility instruments in patients with keratinocyte cancer and actinic keratosis : a cross‐sectional study

Isabelle Hoorens (UGent) , R. Waalboer‐Spuij, Laura Van Coile (UGent) , M. Debaveye, Andrew Shen, Evelien Verhaeghe (UGent) and Lieve Brochez (UGent)

(2022) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 36(11). p.e906-e907
Add to list
- Journal Article
- A1
- open access
Skin cancer detection using infrared thermography : measurement setup, procedure and equipment

Jan Verstockt, Simon Verspeek, Filip Thiessen, Wiebren A. Tjalma, Lieve Brochez (UGent) and Gunther Steenackers

(2022) SENSORS. 22(9).
Add to list
- Miscellaneous
- open access
Systemic treatment of advanced basal cell carcinoma : how to critically evaluate value for patient and society?

Isabelle Hoorens (UGent) , Laura Van Coile (UGent) , Celine Jacobs (UGent) , Michael Saerens (UGent) , Evelien Verhaeghe (UGent) and Lieve Brochez (UGent)

(2022) THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 14.
Add to list
- Journal Article
- A1
The value of measuring uncertainty in neural networks in dermoscopy

Pieter Van Molle (UGent) , Lieve Brochez (UGent) , Tim Verbelen (UGent) , Cedric De Boom, Bert Vankeirsbilck (UGent) , Evelien Verhaeghe (UGent) , Sofie Mylle (UGent) , Pieter Simoens (UGent) and Bart Dhoedt (UGent)

(2022) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 87(5). p.1191-1193
Add to list
- Conference Paper
- C3
Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial

Jan Vanwelkenhuyzen (UGent) , Mathieu Spaas (UGent) , Kim Van der Eecken (UGent) , Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Lieve Brochez (UGent) , Johan Lindberg, Katleen De Preter (UGent) , Bram De Laere (UGent) and Piet Ost (UGent)

(2022) OncoPoint Symposium, 8th, Abstracts.
Add to list
- Journal Article
- A1
- open access
High-resolution 18F-FDG PET/CT for assessing three-dimensional intraoperative margins status in malignancies of the head and neck, a proof-of-concept

Jens Debacker (UGent) , Vanessa Schelfhout (UGent) , Lieve Brochez (UGent) , David Creytens (UGent) , Yves D'Asseler (UGent) , Philippe Deron (UGent) , Vincent Keereman (UGent) , Koen Van de Vijver (UGent) , Christian Vanhove (UGent) and Wouter Huvenne (UGent)

(2021) JOURNAL OF CLINICAL MEDICINE. 10(16).
Add to list
- Journal Article
- A1
- open access
Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures

Annabel Meireson, Simon Tavernier (UGent) , Sofie Van Gassen (UGent) , Nora Sundahl, Annelies Demeyer (UGent) , Mathieu Spaas (UGent) , Vibeke Kruse (UGent) , Liesbeth Ferdinande (UGent) , Jo Van Dorpe (UGent) , Benjamin Hennart, et al.

(2021) CANCERS. 13(11).
Add to list
- Journal Article
- A1
- open access
Lesion‐directed screening to optimize skin cancer detection in dermatology practice : an observational study

Sofie Mylle (UGent) , Evelien Verhaeghe (UGent) , Laura Van Coile (UGent) , Beatrice Van de Maele, Isabelle Hoorens (UGent) and Lieve Brochez (UGent)

(2021) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 35(6). p.1309-1314
Add to list
- Conference Paper
- C3
Three-dimensional margin assessment in head and neck malignancies using a submillimetric 18F-FDG PET/CT, results of an ongoing clinical trial

Jens Debacker (UGent) , David Creytens (UGent) , Lieve Brochez (UGent) , Yves D'Asseler (UGent) , Philippe Deron (UGent) , Nicolas Dhooghe (UGent) , Frederick Dochy, Vincent Keereman (UGent) , Vanessa Schelfhout (UGent) , Peter Tomassen (UGent) , et al.

(2021) ORAL ONCOLOGY. 118(Suppl.). p.5-5
Add to list
- Journal Article
- A1
- open access
Clinical relevance of serum Kyn/Trp ratio and basal and IFN gamma-upregulated IDO1 expression in peripheral monocytes in early stage melanoma

Annabel Meireson, Liesbeth Ferdinande (UGent) , Marc Haspeslagh (UGent) , Benjamin Hennart, Delphine Allorge, Piet Ost (UGent) , Nora Sundahl, Mathieu Spaas (UGent) , Annelies Demeyer (UGent) and Lieve Brochez (UGent)

(2021) FRONTIERS IN IMMUNOLOGY. 12.
Add to list
- Journal Article
- A1
Incidence and survival of cutaneous melanoma in Belgium and the Netherlands from 2004 to 2016 : striking differences and similarities of two neighbouring countries

B. Reyn, E. Van Eycken, M. Louwman, K. Henau, K. Schreuder, Lieve Brochez (UGent) , M. Garmyn and N.A. Kukutsch

(2021) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 35(7). p.1528-1535
Add to list
- Miscellaneous
- open access
Editorial : targeting indoleamine 2,3-dioxygenases and tryptophan dioxygenase for cancer immunotherapy

Lieve Brochez (UGent) , Vibeke Kruse, Dirk Schadendorf, Alexander J. Muller and George C. Prendergast

(2021) FRONTIERS IN IMMUNOLOGY. 12.
Add to list
- Journal Article
- A2
Phototoxicité sous olanzapine et acide valproïque : rapport de cas et revue de la littérature sur les effets secondaires au niveau cutané suite aux antipsychotiques atypiques et à l'acide valproïque

Hannes Dechamps, Lieve Brochez (UGent) , Luk Beelaert, Celine Matton (UGent) and Gilbert Lemmens (UGent)

(2021) ACTA PSYCHIATRICA BELGICA. 121(3). p.19-27
Add to list
- Journal Article
- A1
- open access
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu Spaas (UGent) , Nora Sundahl, Eva Hulstaert, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Veerle Surmont (UGent) , Annabel Meireson, Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2021) BMC CANCER. 21(1).
Add to list
- Miscellaneous
- open access
Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic

Lieve Brochez (UGent) , J.F. Baurain, V. Del Marmol, A. Nikkels, Vibeke Kruse (UGent) , F. Sales, M. Stas, A. Van Laethem and M. Garmyn

(2020) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 34(9). p.1876-1878
Add to list
- Journal Article
- A1
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases

Yanina Jansen, Vibeke Kruse (UGent) , Jurgen Corthals, Kelly Schats, Pieter-Jan van Dam, Teofila Seremet, Carlo Heirman, Lieve Brochez (UGent) , Mark Kockx, Kris Thielemans, et al.

(2020) CANCER IMMUNOLOGY IMMUNOTHERAPY. 69(12). p.2589-2598
Add to list
- Journal Article
- A1
The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype

Niels Vandamme (UGent) , Geertrui Denecker (UGent) , Kenneth Bruneel, Gillian Blancke (UGent) , Ozden Akay, Joachim Taminau (UGent) , Jordy De Coninck (UGent) , Eva De Smedt (UGent) , Nicolas Skrypek (UGent) , Wouter Van Loocke (UGent) , et al.

(2020) CANCER RESEARCH. 80(14). p.2983-2995
Add to list
- Journal Article
- A1
- open access
IDO expression in cancer : different compartment, different functionality?

Annabel Meireson, Michael Devos and Lieve Brochez (UGent)

(2020) FRONTIERS IN IMMUNOLOGY. 11.
Add to list
- Journal Article
- A1
Enhanced visualization of blood and pigment in multispectral skin dermoscopy

Laudine Janssen, Sofie Mylle (UGent) , Sofie Van Kelst, Julie De Smedt, Bart Diricx, Tom Kimpe, Marc Boone, Evelien Verhaeghe (UGent) , Lieve Brochez (UGent) and Marjan Garmyn

(2020) SKIN RESEARCH AND TECHNOLOGY. 26(5). p.708-712
Add to list
- Journal Article
- A1
- open access
Charting extracellular transcriptomes in the human biofluid RNA atlas

Eva Hulstaert, Annelien Morlion (UGent) , Francisco Avila Cobos (UGent) , Kimberly Verniers (UGent) , Justine Nuytens (UGent) , Eveline Vanden Eynde (UGent) , Nurten Yigit (UGent) , Jasper Anckaert (UGent) , Anja Geerts (UGent) , Pieter Hindryckx (UGent) , et al.

(2020) CELL REPORTS. 33(13).
Add to list
- Miscellaneous
Haptoglobin polymorphism and the risk of actinic keratoses and cutaneous squamous cell carcinoma: A case-control study

Lieve Brochez (UGent) , Reinhart Speeckaert (UGent) , Dirk De Bacquer (UGent) , Joris Delanghe (UGent) and Isabelle Hoorens (UGent)

(2019) JOURNAL OF DERMATOLOGY. 46(3). p.274-275
Add to list
- Journal Article
- A1
Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma

Nora Sundahl, Teofila Seremet, Jo Van Dorpe (UGent) , Bart Neyns, Liesbeth Ferdinande, Annabel Meireson, Lieve Brochez (UGent) , Vibeke Kruse (UGent) and Piet Ost (UGent)

(2019) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 104(4). p.828-835
Add to list
- Conference Paper
- C3
Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results

Piet Ost (UGent) , Nora Sundahl, G Vandekerkhove, Karel Decaestecker (UGent) , Annabel Meireson, Pieter De Visschere (UGent) , Valerie Fonteyne (UGent) , Daan De Maeseneer (UGent) , Dries Reynders (UGent) , Els Goetghebeur (UGent) , et al.

(2019) EUROPEAN UROLOGY SUPPLEMENTS. 18(1). p.e2105-e2105
Add to list
- Conference Paper
- C3
Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results

Gillian Vandekerkhove, Nora Sundahl, Karel Decaestecker (UGent) , Annabel Meireson, Pieter De Visschere (UGent) , Valerie Fonteyne (UGent) , Daan De Maeseneer (UGent) , Dries Reynders (UGent) , Els Goetghebeur (UGent) , Jo Van Dorpe (UGent) , et al.

(2019) JOURNAL OF CLINICAL ONCOLOGY. 37(7, suppl. 5).
Add to list
- Conference Paper
- C3
Assessing uncertainty for computer assisted skin lesion diagnosis

Pieter Van Molle (UGent) , Tim Verbelen (UGent) , Bert Vankeirsbilck (UGent) , Sofie Mylle, Evelien Verhaeghe (UGent) , Lieve Brochez (UGent) , Jonas De Vylder (UGent) , Bart Diricx, Pieter Simoens (UGent) and Bart Dhoedt (UGent)

(2019) EADV, 28th Congress, Abstracts.
Add to list
- Journal Article
- A1
- open access
Value of dermoscopy in a population-based screening sample by dermatologists

Isabelle Hoorens (UGent) , Katrien Vossaert (UGent) , Sven Lanssens, Laurence Dierckxsens, Giuseppe Argenziano and Lieve Brochez (UGent)

(2019) DERMATOLOGY PRACTICAL & CONCEPTUAL. 9(3). p.200-206
Add to list
- Journal Article
- A1
Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

Nora Sundahl, Gillian Vandekerkhove, Karel Decaestecker (UGent) , Annabel Meireson, Pieter De Visschere (UGent) , Valerie Fonteyne (UGent) , Daan De Maeseneer (UGent) , Dries Reynders (UGent) , Els Goetghebeur (UGent) , Jo Van Dorpe (UGent) , et al.

(2019) EUROPEAN UROLOGY. 75(5). p.707-711
Add to list
- Conference Paper
- C3
- open access
A study on confidence in classification of skin lesions by deep neural networks

Pieter Van Molle (UGent) , Tim Verbelen (UGent) , Bert Vankeirsbilck (UGent) , Sofie Mylle (UGent) , Evelien Verhaeghe (UGent) , Lieve Brochez (UGent) , Jonas De Vylder, Bart Diricx, Pieter Simoens (UGent) and Bart Dhoedt (UGent)

(2019) OncoPoint, 7th Research seminar, Abstracts.
Add to list
- Conference Paper
- C3
A study on confidence in classification of skin lesions by deep neural networks

Pieter Van Molle (UGent) , Tim Verbelen (UGent) , Bert Vankeirsbilck (UGent) , Sofie Mylle (UGent) , Evelien Verhaeghe (UGent) , Lieve Brochez (UGent) , Jonas De Vylder, Bart Diricx, Pieter Simoens (UGent) and Bart Dhoedt (UGent)

(2019) European Association of Dermato-Oncology, 15th Congress, Abstracts.
Add to list
- Journal Article
- A1
- open access
Immune checkpoint blockade for organ transplant patients with advanced cancer : how far can we go?

Pauline De Bruyn, Dirk Van Gestel, Piet Ost (UGent) , Vibeke Kruse (UGent) , Lieve Brochez (UGent) , Hans Van Vlierberghe (UGent) , Arnaud Devresse, Véronique del Marmol, Alain Le Moine and Sandrine Aspeslagh

(2019) CURRENT OPINION IN ONCOLOGY. 31(2). p.54-64
Add to list
- Journal Article
- A2
Algorithms for molecular testing in solid tumours

A. Hébrant, M. Lammens, C. Van den Broecke, N. D’Haene, J. Van den Oord, A. Vanderstichele, A. Dendooven, P. Neven, K. Punie, G. Floris, et al.

(2019) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 13(7). p.286-295
Add to list
- Conference Paper
- C3
Endothelial indoleamine 2,3-dioxygenase is correlated with microsatellite status in colorectal carcinoma and predicts worse prognosis

Annabel Meireson, INES CHEVOLET (UGent) , Eva Hulstaert, Liesbeth Ferdinande (UGent) , Piet Ost (UGent) , Karen Geboes (UGent) , Marc De Man, Dirk Van de Putte, Laurine Verset, Vibeke Kruse (UGent) , et al.

(2018) OncoPoint, 6th Research seminar, Abstracts.
Add to list
- Journal Article
- A2
- open access
Psoriasis vulgaris exacerbation during treatment with a PD-1 checkpoint inhibitor : case report and literature review

Marlies De Bock, Eva Hulstaert, Vibeke Kruse (UGent) and Lieve Brochez (UGent)

(2018) CASE REPORTS IN DERMATOLOGY. 10(2). p.190-197
Add to list
- Journal Article
- A1
- open access
A CARD9 founder mutation disrupts NF-κB signaling by inhibiting BCL10 and MALT1 recruitment and signalosome formation

Marieke De Bruyne (UGent) , Levi Hoste (UGent) , Delfien Bogaert (UGent) , Lien Van den Bossche, Simon Tavernier (UGent) , Eef Parthoens (UGent) , Mélanie Migaud, Deborah Konopnicki, Jean Cyr Yombi, Bart Lambrecht (UGent) , et al.

(2018) FRONTIERS IN IMMUNOLOGY. 9.
Add to list
- Journal Article
- A1
- open access
Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma

Lieve Brochez (UGent) , Annabel Meireson, INES CHEVOLET (UGent) , Nora Sundahl, Piet Ost (UGent) and Vibeke Kruse (UGent)

(2018) NATURE COMMUNICATIONS. 9.
Add to list
- Journal Article
- A1
Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma

Nora Sundahl, Katrien De Wolf, Vibeke Kruse (UGent) , Annabel Meireson, Dries Reynders (UGent) , Els Goetghebeur (UGent) , Mireille Van Gele (UGent) , Reinhart Speeckaert (UGent) , Benjamin Hennart, Lieve Brochez (UGent) , et al.

(2018) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 100(4). p.906-915
Add to list
- Journal Article
- A1
- open access
A longitudinal analysis of IDO and PDL1 expression during immune- or targeted therapy in advanced melanoma

Lukas Krähenbühl, Simone M Goldinger, Joanna Mangana, Katrin Kerl, Ines Chevolet, Lieve Brochez (UGent) , Christine Horak, Mitch Levesque, Reinhard Dummer and Phil F Cheng

(2018) NEOPLASIA. 20(2). p.218-225
Add to list
- Journal Article
- A2
- open access
Peritumoral endothelial indoleamine 2,3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile

Annabel Meireson, INES CHEVOLET (UGent) , Eva Hulstaert, Liesbeth Ferdinande (UGent) , Piet Ost (UGent) , Karen Geboes (UGent) , Marc De Man (UGent) , Dirk Van de Putte (UGent) , Laurine Verset, Vibeke Kruse (UGent) , et al.

(2018) ONCOTARGET. 9(38). p.25216-25224
Add to list
- Journal Article
- A1
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy

Lieve Brochez (UGent) , INES CHEVOLET (UGent) and Vibeke Kruse (UGent)

(2017) EUROPEAN JOURNAL OF CANCER. 76. p.167-182
Add to list
- Journal Article
- A1
- open access
Long non-coding RNAs in cutaneous melanoma : clinical perspectives

Eva Hulstaert, Lieve Brochez (UGent) , Pieter-Jan Volders (UGent) , Jo Vandesompele (UGent) and Pieter Mestdagh (UGent)

(2017) ONCOTARGET. 8(26). p.43470-43480
Add to list
- Journal Article
- A1
Cost-effectiveness and budget effect analysis of a population-based skin cancer screening

Lore Pil (UGent) , Isabelle Hoorens (UGent) , Katrien Vossaert (UGent) , Vibeke Kruse (UGent) , Isabelle Tromme, Niko Speybroeck, Lieven Annemans (UGent) and Lieve Brochez (UGent)

(2017) JAMA DERMATOLOGY. 153(2). p.147-153
Add to list
- Journal Article
- A1
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma

Birgit Geoerger, Christophe Bergeron, Lia Gore, Leonard Sender, Ira J Dunkel, Cynthia Herzog, Lieve Brochez (UGent) , Ofelia Cruz, Karsten Nysom, Elmer Berghorn, et al.

(2017) EUROPEAN JOURNAL OF CANCER. 86. p.358-363
Add to list
- Journal Article
- A1
- open access
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response

Katrien De Wolf, VIBEKE KRUSE (UGent) , Nora Sundahl, Mireille Van Gele (UGent) , INES CHEVOLET (UGent) , Reinhart Speeckaert (UGent) , Lieve Brochez (UGent) and Piet Ost (UGent)

(2017) JOURNAL OF TRANSLATIONAL MEDICINE. 15.
Add to list
- Journal Article
- A1
- open access
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response

Nora Sundahl, Katrien De Wolf, Sylvie Rottey (UGent) , Karel Decaestecker (UGent) , Daan De Maeseneer (UGent) , Annabel Meireson, Els Goetghebeur (UGent) , Valerie Fonteyne (UGent) , Sofie Verbeke (UGent) , Pieter De Visschere (UGent) , et al.

(2017) JOURNAL OF TRANSLATIONAL MEDICINE. 15.
Add to list
- Journal Article
- A2
The ION-Ghent guidelines for the management of immune related adverse events (irAE's)

Vibeke Kruse (UGent) , Max Schreuer (UGent) , Karim Vermaelen (UGent) , Piet Ost (UGent) , Tessa Kerre (UGent) , Barbara De Moerloose (UGent) and Lieve Brochez (UGent)

(2017) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 11(6). p.265-275
Add to list
- Journal Article
- A2
Bijwerkingen van 'immune checkpoint' inhibitoren : waar dient een huisarts alert op te zijn?

S De Keukeleire, Tessa Kerre (UGent) , Piet Ost (UGent) , Barbara De Moerloose (UGent) , Karim Vermaelen (UGent) , Lieve Brochez (UGent) and Vibeke Kruse (UGent)

(2017) TIJDSCHRIFT VOOR GENEESKUNDE. 73(18). p.1105-1111
Add to list
- Journal Article
- A1
Total-body examination vs lesion-directed skin cancer screening

Isabelle Hoorens (UGent) , Katrien Vossaert, Lore Pil (UGent) , Barbara Boone (UGent) , Sofie De Schepper (UGent) , Katia Ongenae (UGent) , Lieven Annemans (UGent) , INES CHEVOLET (UGent) and Lieve Brochez (UGent)

(2016) JAMA DERMATOLOGY. 152(1). p.27-34
Add to list
- Journal Article
- A2
Virale oncogenese van het merkelcelcarcinoom

Eva Hulstaert, INES CHEVOLET (UGent) , Vibeke Kruse (UGent) and Lieve Brochez (UGent)

(2016) TIJDSCHRIFT VOOR GENEESKUNDE. 72(9). p.557-562
Add to list
- Journal Article
- A1
Chronic and invasive fungal infections in a family with CARD9 deficiency

Ana Alves de Medeiros (UGent) , EVELYNE LODEWICK (UGent) , Delfien Bogaert (UGent) , Filomeen Haerynck (UGent) , Sabine Van daele (UGent) , Bart Lambrecht (UGent) , Sarah Bosma (UGent) , Laure Vanderdonckt, Olivier Lortholary, Mélanie Migaud, et al.

(2016) JOURNAL OF CLINICAL IMMUNOLOGY. 36(3). p.204-209
Add to list
- Journal Article
- A1
Successful strategy to treat a solitary cystic melanoma brain metastasis

Vibeke Kruse (UGent) , Tom Boterberg (UGent) , Marjan Acou (UGent) , David Creytens (UGent) , Caroline Van den Broecke (UGent) , Lieve Brochez (UGent) and Giorgio Hallaert (UGent)

(2016) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 31(4). p.e216-e217
Add to list
- Journal Article
- A1
- open access
Pathologic evaluation of skin tumors with ex vivo dermoscopy with derm dotting

Marc Haspeslagh (UGent) , Isabelle Hoorens (UGent) , Nele Degryse, Ine De Wispelaere, Annemarie Degroote, Sarah Van Belle, Jan Verboven, Katrien Vossaert (UGent) , Fabio Facchetti, Jo Van Dorpe (UGent) , et al.

(2016) JAMA DERMATOLOGY. 153(2). p.154-160
Add to list
- Journal Article
- A1
Chemoprevention of basal cell carcinoma : reply from authors

Isabelle Hoorens (UGent) and Lieve Brochez (UGent)

(2016) BRITISH JOURNAL OF DERMATOLOGY. 175(6). p.1404-1405
Add to list
- Journal Article
- A1
Successful treatment of HCV-associated B-cell non-Hodgkin lymphomas with direct-acting antiviral agents

FREDERIK DE CLERCK (UGent) , Anja Geerts (UGent) , Lieve Brochez (UGent) , Reinhart Speeckaert (UGent) , Tom Boterberg (UGent) , Hans Van Vlierberghe (UGent) and Xavier Verhelst (UGent)

(2016) JOURNAL OF CLINICAL GASTROENTEROLOGY. 50(5). p.438-438
Add to list
- Journal Article
- A1
- open access
Comparison of ex vivo and in vivo dermoscopy in dermatopathologic evaluation of skin tumors

Marc Haspeslagh (UGent) , Katrien Vossaert (UGent) , Sven Lanssens, Michael Noe, Isabelle Hoorens (UGent) , INES CHEVOLET (UGent) , Ine De Wispelaere, Nele Degryse, Fabio Facchetti and Lieve Brochez (UGent)

(2016) JAMA DERMATOLOGY. 152(3). p.312-317
Add to list
- Journal Article
- A1
Rosettes and other white shiny structures in polarized dermoscopy: histological correlate and optical explanation

Marc Haspeslagh (UGent) , M Noë, I De Wispelaere, N Degryse, Katrien Vossaert (UGent) , Sven Lanssens, F Facchetti, K Van den Bossche and Lieve Brochez (UGent)

(2016) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 30(2). p.311-313
Add to list
- Miscellaneous
Chronic and invasive fungal infections in a family with CARD9 deficiency (vol 36, pg 204, 2016)

Ana Karina Alves de Medeiros, EVELYNE LODEWICK (UGent) , Delfien Bogaert (UGent) , Filomeen Haerynck (UGent) , Sabine Van daele (UGent) , Bart Lambrecht (UGent) , Sarah Bosma (UGent) , Laure Vanderdonckt, Olivier Lortholary, Mélanie Migaud, et al.

(2016) JOURNAL OF CLINICAL IMMUNOLOGY. 36(5). p.528-528
Add to list
- Journal Article
- A1
Burden of skin cancer in Belgium and cost-effectiveness of primary prevention by reducing ultraviolet exposure

Lore Pil (UGent) , Isabelle Hoorens (UGent) , Katrien Vossaert (UGent) , VIBEKE KRUSE (UGent) , Isabelle Tromme, Niko Speybroeck, Lieve Brochez (UGent) and Lieven Annemans (UGent)

(2016) PREVENTIVE MEDICINE. 93. p.177-182
Add to list
- Journal Article
- A1
Is early detection of basal cell carcinoma worthwhile? : systematic review based on the WHO criteria for screening

Isabelle Hoorens (UGent) , Katrien Vossaert (UGent) , Katia Ongenae (UGent) and Lieve Brochez (UGent)

(2016) BRITISH JOURNAL OF DERMATOLOGY. 174(6). p.1258-1265
Add to list
- Conference Paper
- C3
Cost-effectiveness of population-based skin cancer screening

Isabelle Hoorens (UGent) , Lore Pil (UGent) , Katrien Vossaert (UGent) , Lieven Annemans (UGent) and Lieve Brochez (UGent)

(2016) MELANOMA RESEARCH. 26(suppl. 1). p.E21-E21
Add to list
- Journal Article
- A1
- open access
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma

INES CHEVOLET (UGent) , Reinhart Speeckaert (UGent) , Max Schreuer (UGent) , Bart Neyns, Olga Krysko (UGent) , Claus Bachert (UGent) , Mireille Van Gele (UGent) , Nanja van Geel (UGent) and Lieve Brochez (UGent)

(2015) JOURNAL OF TRANSLATIONAL MEDICINE. 13.
Add to list
- Journal Article
- A1
A short dermoscopy training increases diagnostic performance in both inexperienced and experienced dermatologists

INES CHEVOLET (UGent) , Isabelle Hoorens (UGent) , Astrid Janssens, Reinhart Speeckaert (UGent) , Nanja van Geel (UGent) , GEORGES VAN MAELE (UGent) , Katrien Vossaert (UGent) and Lieve Brochez (UGent)

(2015) AUSTRALASIAN JOURNAL OF DERMATOLOGY. 56(1). p.52-55
Add to list
- Journal Article
- A1
Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma

INES CHEVOLET (UGent) , Reinhart Speeckaert (UGent) , Max Schreuer (UGent) , B Neyns, Olga Krysko (UGent) , Claus Bachert (UGent) , B Hennart, D Allorge, Nanja van Geel (UGent) , Mireille Van Gele (UGent) , et al.

(2015) ONCOIMMUNOLOGY. 4(3).
Add to list
- Journal Article
- A1
Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients: failure at the effector phase?

INES CHEVOLET (UGent) , Max Schreuer (UGent) , Reinhart Speeckaert (UGent) , Bart Neyns, Isabelle Hoorens (UGent) , Nanja van Geel (UGent) , Vibeke Kruse (UGent) , Benjamin Hennart, Delphine Allorge, Mireille Van Gele (UGent) , et al.

(2015) MELANOMA RESEARCH. 25(4). p.357-361
Add to list
- Miscellaneous
- open access
Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2

Jo Robays, Sabine Stordeur, Frank Hulstaert, Jean-François Baurain, Lieve Brochez (UGent) , Teofila Caplanusi, Kathleen Claes (UGent) , Eric Legius, Sylvie Rottey (UGent) , Dirk Schrijvers, et al.

(2015) KCE Report. 243.
Add to list
- Conference Paper
- C3
Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect

Katrien De Wolf, Piet Ost (UGent) , VIBEKE KRUSE (UGent) , Lieve Brochez (UGent) and INES CHEVOLET (UGent)

(2015) ANNALS OF ONCOLOGY. 26(suppl. 8). p.7-7
Add to list
- Journal Article
- A1
A cross-sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis

JESSICA BOSTOEN (UGent) , L Van Praet, Lieve Brochez (UGent) , Herman Mielants (UGent) and Jo Lambert (UGent)

(2014) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 28(4). p.507-511
Add to list
- Journal Article
- A1
Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression

Geertrui Denecker (UGent) , Niels Vandamme (UGent) , Ozden Akay, D Koludrovic, Joachim Taminau (UGent) , Kelly Lemeire (UGent) , Alexander Gheldof (UGent) , Bram De Craene (UGent) , Mireille Van Gele (UGent) , Lieve Brochez (UGent) , et al.

(2014) CELL DEATH AND DIFFERENTIATION. 21(8). p.1250-1261
Add to list
- Journal Article
- A1
- open access
Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports

Joke Marlier (UGent) , Veronique Cocquyt (UGent) , Lieve Brochez (UGent) , Simon Van Belle (UGent) and VIBEKE KRUSE (UGent)

(2014) ENDOCRINE. 47(3). p.878-883
Add to list
- Journal Article
- A1
Efficacy of products to remove eggs of Pediculus humanus capitis (Phthiraptera: Pediculidae) from the human hair

Hilde Lapeere (UGent) , Lieve Brochez (UGent) , Evelien Verhaeghe (UGent) , Robert Vander Stichele (UGent) , Jean Paul Remon (UGent) , Jo Lambert (UGent) and Luc Leybaert (UGent)

(2014) JOURNAL OF MEDICAL ENTOMOLOGY. 51(2). p.400-407
Add to list
- Journal Article
- A1
Peritumoral indoleamine 2,3-dioxygenase expression in melanoma : an early marker of resistance to immune control?

INES CHEVOLET (UGent) , Reinhart Speeckaert (UGent) , Marc Haspeslagh (UGent) , Bart Neyns, VIBEKE KRUSE (UGent) , Max Schreuer (UGent) , Mireille Van Gele (UGent) , Nanja van Geel (UGent) and Lieve Brochez (UGent)

(2014) BRITISH JOURNAL OF DERMATOLOGY. 171(5). p.987-995
Add to list
- Journal Article
- A1
Clinical profile of generalized vitiligo patients with associated autoimmune/autoinflammatory diseases

Nanja van Geel (UGent) , Marijn Speeckaert (UGent) , Lieve Brochez (UGent) , Jo Lambert (UGent) and Reinhart Speeckaert (UGent)

(2014) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 28(6). p.741-746
Add to list
- Journal Article
- A1
- open access
Cancer risk in immune-mediated inflammatory diseases (IMID)

Rudi Beyaert (UGent) , Laurent Beaugerie, Gert Van Assche, Lieve Brochez (UGent) , Jean-Christophe Renauld, Manuelle Viguier, Veronique Cocquyt (UGent) , Guy Jerusalem, Jean-Pascal Machiels, Hans Prenen, et al.

(2013) MOLECULAR CANCER. 12.
Add to list
- Journal Article
- A1
miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells

Peter Dynoodt (UGent) , Reinhart Speeckaert (UGent) , Olivier De Wever (UGent) , INES CHEVOLET (UGent) , Lieve Brochez (UGent) , Jo Lambert (UGent) and Mireille Van Gele (UGent)

(2013) INTERNATIONAL JOURNAL OF ONCOLOGY. 42(4). p.1443-1451
Add to list
- Journal Article
- A1
- open access
The distribution pattern of segmental vitiligo: clues for somatic mosaicism

Nanja van Geel (UGent) , Reinhart Speeckaert (UGent) , Elodie Melsens, SP Toelle, Marijn Speeckaert (UGent) , Sofie De Schepper (UGent) , Jo Lambert (UGent) and Lieve Brochez (UGent)

(2013) BRITISH JOURNAL OF DERMATOLOGY. 168(1). p.56-64
Add to list
- Conference Paper
- C3
The effect of CD8+tumor-infiltrating lymphocytes on sentinel lymph node immune status

INES CHEVOLET (UGent) , Reinhart Speeckaert (UGent) , Barbara Boone (UGent) , Nanja van Geel (UGent) , Mireille Van Gele (UGent) , Marc Haspeslagh (UGent) and Lieve Brochez (UGent)

(2013) JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 11(suppl. 7). p.17-18
Add to list
- Book Chapter
Hypomelanoses and hypermelanoses

Hilde Lapeere (UGent) , Barbara Boone (UGent) , Sofie De Schepper (UGent) , Evelien Verhaeghe (UGent) , Mireille Van Gele (UGent) , Katia Ongenae (UGent) , Nanja van Geel (UGent) , Jo Lambert (UGent) and Lieve Brochez (UGent)

(2012) Fitzpatrick’s dermatology in general medicine. p.804-826
Add to list
- Journal Article
- A1
Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients

Reinhart Speeckaert (UGent) , Karim Vermaelen (UGent) , Nanja van Geel (UGent) , Philippe Autier, Jo Lambert (UGent) , Marc Haspeslagh (UGent) , Mireille Van Gele (UGent) , Kris Thielemans, Bart Neyns, Nathalie Roche (UGent) , et al.

(2012) EUROPEAN JOURNAL OF CANCER. 48(13). p.2004-2011
Add to list
- Journal Article
- A1
In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial

Nanja van Geel (UGent) , Reinhart Speeckaert (UGent) , ILSE MOLLET (UGent) , Sofie De Schepper (UGent) , Julie De Wolf, Esther PM Tjin, Rosalie M Luiten, Jo Lambert (UGent) and Lieve Brochez (UGent)

(2012) PIGMENT CELL & MELANOMA RESEARCH. 25(1). p.57-65
Add to list
- Journal Article
- A1
New insights in segmental vitiligo: case report and review of theories

Nanja van Geel (UGent) , ILSE MOLLET (UGent) , Lieve Brochez (UGent) , MARIEKE DUTRE, Sofie De Schepper (UGent) , Evelien Verhaeghe (UGent) , Jo Lambert (UGent) and Reinhart Speeckaert (UGent)

(2012) BRITISH JOURNAL OF DERMATOLOGY. 166(2). p.240-246
Add to list
- Journal Article
- A1
The haptoglobin phenotype influences the risk of cutaneous squamous cell carcinoma in kidney transplant patients

Reinhart Speeckaert (UGent) , Lieve Brochez (UGent) , Jo Lambert (UGent) , Nanja van Geel (UGent) , Marijn Speeckaert (UGent) , LAURENS CLAEYS (UGent) , Michel Langlois (UGent) , C Van Laer, Patrick Peeters (UGent) and Joris Delanghe (UGent)

(2012) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 26(5). p.566-571
Add to list
- Miscellaneous
Immune mediated mechanisms of melanocyte destruction: paving the way for efficient immunotherapeutic strategies against melanoma

Reinhart Speeckaert (UGent) , Nanja van Geel (UGent) , Jo Lambert (UGent) , Barbara Boone (UGent) , INES CHEVOLET (UGent) , Mireille Van Gele (UGent) , Marijn Speeckaert (UGent) and Lieve Brochez (UGent)

(2012) ONCOIMMUNOLOGY. 1(4). p.526-528
Add to list
- Journal Article
- A1
Clinical significance of Koebner's phenomenon in vitiligo

Nanja van Geel (UGent) , Reinhart Speeckaert (UGent) , J De Wolf, STEFANIE BRACKE (UGent) , INES CHEVOLET (UGent) , Lieve Brochez (UGent) and Jo Lambert (UGent)

(2012) BRITISH JOURNAL OF DERMATOLOGY. 167(5). p.1017-1024

Case series of kaposi sarcoma in HIV-negative men who have sex with men : potential therapeutic approaches

Cost-of-illness of skin cancer : a systematic review

Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them.

The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study

Angiosarcoma mimicking rhinophyma

Dermatologist versus artificial intelligence confidence in dermoscopy diagnosis : complementary information that may affect decision-making

Comparative analysis of cooling methods for dynamic infrared thermography (DIRT)-based skin cancer diagnosis

Impact of the COVID-19 pandemic on the incidence and thickness of cutaneous melanoma in Belgium

Can multispectral dermoscopy help in distinguishing blue color?

European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023

Cost-of-illness of skin cancer : a systematic literature review

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Truth or dare : switching BRAF/MEK inhibitors after acute interstitial nephritis in a patient with metastatic melanoma : a case report and review of the literature

The therapeutic dilemma of basal cell carcinoma in older adults : a review of the current literature

A critical re‐evaluation of Mohs micrographic surgery for a facial basal cell carcinoma in older adults : should we waive this treatment in certain patients?

Study protocol of the BASINEL Study : a pragmatic randomised controlled trial investigating treatment versus no treatment of low-risk basal cell carcinomas in older persons

Response to the comment by Suijkerbuijk et al. ‘Survival of stage IV melanoma in Belgium and the Netherlands’

Basal cell carcinoma in older adults : how to decide when active surveillance or watchful waiting are appropriate?

Health state utility instruments in patients with keratinocyte cancer and actinic keratosis : a cross‐sectional study

Skin cancer detection using infrared thermography : measurement setup, procedure and equipment

Systemic treatment of advanced basal cell carcinoma : how to critically evaluate value for patient and society?

The value of measuring uncertainty in neural networks in dermoscopy

Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial

High-resolution 18F-FDG PET/CT for assessing three-dimensional intraoperative margins status in malignancies of the head and neck, a proof-of-concept

Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures

Lesion‐directed screening to optimize skin cancer detection in dermatology practice : an observational study

Three-dimensional margin assessment in head and neck malignancies using a submillimetric 18F-FDG PET/CT, results of an ongoing clinical trial

Clinical relevance of serum Kyn/Trp ratio and basal and IFN gamma-upregulated IDO1 expression in peripheral monocytes in early stage melanoma

Incidence and survival of cutaneous melanoma in Belgium and the Netherlands from 2004 to 2016 : striking differences and similarities of two neighbouring countries

Editorial : targeting indoleamine 2,3-dioxygenases and tryptophan dioxygenase for cancer immunotherapy

Phototoxicité sous olanzapine et acide valproïque : rapport de cas et revue de la littérature sur les effets secondaires au niveau cutané suite aux antipsychotiques atypiques et à l'acide valproïque

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic

A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases

The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype

IDO expression in cancer : different compartment, different functionality?

Enhanced visualization of blood and pigment in multispectral skin dermoscopy

Charting extracellular transcriptomes in the human biofluid RNA atlas

Haptoglobin polymorphism and the risk of actinic keratoses and cutaneous squamous cell carcinoma: A case-control study

Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma

Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results

Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results

Assessing uncertainty for computer assisted skin lesion diagnosis

Value of dermoscopy in a population-based screening sample by dermatologists

Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

A study on confidence in classification of skin lesions by deep neural networks

A study on confidence in classification of skin lesions by deep neural networks

Immune checkpoint blockade for organ transplant patients with advanced cancer : how far can we go?

Algorithms for molecular testing in solid tumours

Endothelial indoleamine 2,3-dioxygenase is correlated with microsatellite status in colorectal carcinoma and predicts worse prognosis

Psoriasis vulgaris exacerbation during treatment with a PD-1 checkpoint inhibitor : case report and literature review

A CARD9 founder mutation disrupts NF-κB signaling by inhibiting BCL10 and MALT1 recruitment and signalosome formation

Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma

Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma

A longitudinal analysis of IDO and PDL1 expression during immune- or targeted therapy in advanced melanoma

Peritumoral endothelial indoleamine 2,3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile

The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy

Long non-coding RNAs in cutaneous melanoma : clinical perspectives

Cost-effectiveness and budget effect analysis of a population-based skin cancer screening

Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response

The ION-Ghent guidelines for the management of immune related adverse events (irAE's)

Bijwerkingen van 'immune checkpoint' inhibitoren : waar dient een huisarts alert op te zijn?

Total-body examination vs lesion-directed skin cancer screening

Virale oncogenese van het merkelcelcarcinoom

Chronic and invasive fungal infections in a family with CARD9 deficiency

Successful strategy to treat a solitary cystic melanoma brain metastasis

Pathologic evaluation of skin tumors with ex vivo dermoscopy with derm dotting

Chemoprevention of basal cell carcinoma : reply from authors

Successful treatment of HCV-associated B-cell non-Hodgkin lymphomas with direct-acting antiviral agents

Comparison of ex vivo and in vivo dermoscopy in dermatopathologic evaluation of skin tumors

Rosettes and other white shiny structures in polarized dermoscopy: histological correlate and optical explanation

Chronic and invasive fungal infections in a family with CARD9 deficiency (vol 36, pg 204, 2016)

Burden of skin cancer in Belgium and cost-effectiveness of primary prevention by reducing ultraviolet exposure

Is early detection of basal cell carcinoma worthwhile? : systematic review based on the WHO criteria for screening

Cost-effectiveness of population-based skin cancer screening

Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma

A short dermoscopy training increases diagnostic performance in both inexperienced and experienced dermatologists

Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma